Kantara Initiative and SAFE-BioPharma Support/Promote NSTIC Principles

Kantara Initiative and SAFE-BioPharma Support/Promote NSTIC Principles

<0> Kantara InitiativeJoni Brennan, 732-226-4223orSAFE-BioPharma AssociationJon Weisberg, 801-359-9977mobile: 801-860-9977 </0>

Two of the world’s leading identity trust organizations have pledged to adopt the four principles of the National Strategy for Trusted Identities in Cyberspace (), the White House initiative to improve the privacy, security and convenience of sensitive online transactions. The organizations are the , which helps organizations, globally, establish verified trust in use of digital identities for business and government services, and , which provides a global digital identity and digital signature standard for the life sciences.

The goals of NSTIC are to protect individuals, businesses and public agencies from the high costs of cyber-crimes, while simultaneously ensuring Internet support of innovation and its role as a marketplace of products and ideas. Toward that end, NSTIC calls for development of an – interoperable technology standards and policies – in which individuals, organizations and underlying infrastructure such as routers and servers can be authoritatively authenticated.

The four NSTIC principles which Kantara Initiative and SAFE-BioPharma will promote within their own and related communities of interest are: 1) Privacy Enhancing and Voluntary; 2) Secure and Resilient; 3) Interoperable; and 4) Cost-Effective and Easy-To-Use.

The two groups will meet regularly and take action to overcome obstacles in achieving their stated goals. They also will engage in proactive communications to facilitate discussion with related global, regional and local communities.

Suggested Articles

Women and family health startup Maven landed $45 million in series C funding with some high-profile backers.

Over 41 million patient records were breached in 2019 as the healthcare industry faces new hacking techniques and threats.

With the promotion of Don Trigg, Cerner has named its first new president since 2018.